Medscape.com Story Source Kevin Whelan, Eamonn M.M. Quigley Curr Opin Gastroenterol. 2013;29(2):184-189. Abstract and Introduction Abstract Purpose of review There is direct evidence that the pathogenesis of inflammatory bowel disease (IBD) involves the gastrointestinal microbiota and some evidence that the microbiota might also play a similar role in irritable bowel syndrome (IBS). The aim of this […]
Nutrients. 2013 Aug; 5(8): 3062–3073. Published online 2013 Aug 2. doi: 10.3390/nu5083062 PMCID: PMC3775242 PMID: 23917169 Heidrun Mehling Abstract Prevalence of infections by Helicobacter pylori, a pathogen involved in a number of gastrointestinal diseases, remains high in developing countries. Management of infections by eradication is not always an option. Lactobacillus reuteri (L. reuteri) DSMZ17648 (Pylopass™/Lonza) specifically co-aggregates H. pylori in […]
A Randomised Controlled Trial of a Probiotic ‘Functional Food’ in the Management of Irritable Bowel Syndrome Lesley M Roberts, Deborah McCahon, Roger Holder, Sue Wilson, FD Richard Hobbs BMC Gastroenterol. 2013;13(45) Abstract Background Irritable Bowel Syndrome (IBS) is a common condition characterised by pain, distension and altered bowel habit. Evidence suggests functional foods containing probiotics […]
Megan Brooks May 30, 2013 A new study provides the first evidence in humans that probiotics in the diet can modulate brain activity. In a proof-of-concept study using functional MRI (fMRI), researchers found that women who regularly consumed probiotic-containing yogurt showed altered activity of brain regions that control central processing of emotion and sensation. The […]
by ROB STEIN April 24, 2013 6:01 PM ET Scientists have discovered what may be an important new risk factor for heart disease. And here’s the surprising twist: The troublesome substance seems to be a waste product left behind by bacteria in our guts as they help us digest lecithin — a substance plentiful in […]
Manfred Lamprecht, PhD, PhD Adj. Professor Centre for Physiological Medicine Medical University of Graz Harrachgasse 21/II 8010 Graz, AUSTRIA +436641555528 / +433163809610 (FAX) manfred.lamprecht@medunigraz.at / www.medunigraz.at “Probiotic Supplementation Affects Markers of Intestinal Barrier, Oxidation, and Inflammation in Trained Men; A Randomized, Double-Blinded, Placebo-Controlled Trial,” J Int Soc Sports Nutr, 2012 Sep 20; 9(1):45. 49368 (11/2012) […]
Sandra Yin November 08, 2011 November 8, 2011 (National Harbor/Washington, DC) — Mounting evidence is building a strong case for the use of probiotics, or “good” bacteria, to alleviate common gastrointestinal (GI) symptoms, such as diarrhea, bloating, and inflammation, according to several studies highlighted during a press briefing here at the American College of Gastroenterology […]
April 20, 2011 — In a randomized, double-blind phase 2 study, an intravaginal probiotic composed of Lactobacillus crispatus CTV-05 (Lactin-V, Osel Inc) reduced the rate of recurrent urinary tract infection (rUTI) in UTI-prone women by roughly one half, which compares favorably with historical data on antimicrobial prophylaxis, the researchers say. They add that larger trials […]
Effect of lactobacilli on paracellular permeability in the gut. Authors Ahrne S, et al. Journal Nutrients. 2011 Jan;3(1):104-17. doi: 10.3390/nu3010104. Epub 2011 Jan 12. Affiliation Abstract Paracellular permeability is determined by the complex structures of junctions that are located between the epithelial cells. Already in 1996, it was shown that the human probiotic strain Lactobacillus plantarum […]
In an article published in the Journal of the Australian Traditional-Medicine Society by a PhD student, he outlined different uses for different probiotics. Different probiotic strains have different characteristics and thereby do different actions in the body. For instance, you would use different probiotics to support eczema, food allergies and lowered immunity. Read more…
Isolauri E, Kirjavainen PV, Salminen S Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 2002;50:iii54-iii59. Abstract Probiotic therapy is based on the concept of normal healthy microflora. The development of novel means of characterising the gut microflora, in particular those based on the different levels of conservation in the ribosomal RNA […]